Literature DB >> 3889055

Differing effects of antiinsulin serum and antiinsulin receptor serum on 123I-insulin metabolism in rats.

J C Sodoyez, F Sodoyez Goffaux, R von Frenckell, C J De Vos, S Treves, C R Kahn.   

Abstract

Anesthetized rats were treated with saline, antiinsulin receptor serum, or antiinsulin serum, and the biodistribution of high pressure liquid chromatography-purified 123I-Tyr A14-insulin was studied by scintillation scanning. Time activity curves over organs of interest were calibrated by sacrificing the rats at the end of the experiment and directly determining the radioactivity in the blood, liver, and kidneys. Saline-treated rats exhibited normal insulin biodistribution. The highest concentration of 123I-insulin was found in the liver, and reached 30% of total injected dose between 3 and 5 min after injection. After this peak, activity rapidly decreased with a t1/2 of 6 min. Activity of 123I-insulin in kidney showed a more gradual rise and fall and was approximately 15% of injected dose at its maximum. In rats treated with antiinsulin antiserum, insulin biodistribution was markedly altered. Peak liver activity increased with increasing antibody concentration with up to 90% of injected dose appearing in the liver. In addition, there was no clearance of the liver 123I-insulin over 30 min. Autoradiographic studies demonstrated that in contrast to the normal rats in which radioactivity was associated with hepatocytes, in rats passively immunized with anti-insulin serum, 125I-insulin was associated primarily with the Kuppfer cells. In contrast, antibodies to the insulin receptor markedly inhibited 123I-insulin uptake by the liver. Kidney activity increased, reflecting the amount of free 123I-insulin that reached this organ. This is similar to the pattern observed when insulin receptors are saturated with a high concentration of unlabeled insulin. Thus, both insulin antibodies and anti-receptor antibodies alter the distribution of insulin, but with very different patterns. The use of 123I-insulin and scintillation scanning allows one to study specific alterations in insulin distribution in animal models of insulin-resistant states, and should also be useful in human disease states.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3889055      PMCID: PMC425483          DOI: 10.1172/JCI111848

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  Insulin uptake in the renal proximal tubule.

Authors:  J E Bourdeau; E R Chen; F A Carone
Journal:  Am J Physiol       Date:  1973-12

2.  Effect of renal disease on renal uptake and excretion of insulin in man.

Authors:  R Rabkin; N M Simon; S Steiner; J A Colwell
Journal:  N Engl J Med       Date:  1970-01-22       Impact factor: 91.245

3.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

4.  [127-I]- or carrier-free [125-I]monoiodoinsulin.

Authors:  J C Sodoyez; F Sodoyez-Goffaux; M M Goff; A E Zimmerman; E R Arquilla
Journal:  J Biol Chem       Date:  1975-06-10       Impact factor: 5.157

5.  Effects of insulin antibodies on bioavailability of insulin: preliminary studies using 123I-insulin in patients with insulin-dependent diabetes.

Authors:  J C Sodoyez; F Sodoyez-Goffaux
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

Review 6.  The renal metabolism of insulin.

Authors:  R Rabkin; M P Ryan; W C Duckworth
Journal:  Diabetologia       Date:  1984-09       Impact factor: 10.122

7.  Binding of insulin to its receptor impairs recognition by monoclonal anti-insulin antibodies.

Authors:  S I Taylor; J A Schroer; B Marcus-Samuels; A McElduff; T P Bender
Journal:  Diabetes       Date:  1984-08       Impact factor: 9.461

8.  Metabolism of proinsulin, insulin, and C-peptide in the rat.

Authors:  A I Katz; A H Rubenstein
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

9.  Insulin binding sites in various segments of the rabbit nephron.

Authors:  R Nakamura; D S Emmanouel; A I Katz
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

10.  Clinical disorders associated with autoantibodies to the insulin receptor. Simulation by passive transfer of immunoglobulins to rats.

Authors:  R F Dons; R Havlik; S I Taylor; K L Baird; S S Chernick; P Gorden
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

View more
  3 in total

1.  Hepatic 123I-insulin binding kinetics in non-insulin-dependent (type 2) diabetic patients after i.v. bolus administration.

Authors:  M Oolbekkink; R J Heine; W den Hollander; J J Nauta; E A van der Veen
Journal:  Eur J Nucl Med       Date:  1989

2.  Scintigraphic distribution of complexes of antiinsulin antibodies and 123I-insulin. In vivo studies in rats.

Authors:  F Sodoyez-Goffaux; J C Sodoyez; M Koch; N Dozio; E R Arquilla; B McDougall; C J De Vos; R von Frenckell
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

3.  Scintigraphic distribution of 123 I labelled proinsulin, split conversion intermediates and insulin in rats.

Authors:  F Sodoyez-Goffaux; J C Sodoyez; M Koch; C J De Vos; B H Frank
Journal:  Diabetologia       Date:  1988-11       Impact factor: 10.122

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.